Hirotaka Takahashi Selected Research

N,N'- bis- (2,4- dimethyl- phenyl)- ethane- 1,2- diamine

1/2018

DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirotaka Takahashi Research Topics

Disease

7	Infections 01/2016 - 02/2003
5	Paralysis (Palsy) 12/2013 - 02/2003
4	Neoplasms (Cancer) 01/2019 - 05/2009
4	Facial Paralysis (Facial Palsy) 12/2013 - 03/2005
3	Inflammation (Inflammations) 11/2019 - 02/2016
3	Bell Palsy (Bell's Palsy) 12/2013 - 11/2003
2	Allergic Rhinitis 12/2016 - 02/2016
2	Otitis Media with Effusion 04/2014 - 02/2011
1	Arthritis (Polyarthritis) 01/2019
1	Multiple Myeloma 01/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Dent Disease 01/2017
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Leukemia 01/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Hypercalciuria 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2017
1	T-Cell Leukemia (Leukemia, T Cell) 01/2017
1	Genetic Translocation (Chromosomal Translocation) 01/2017
1	Proteinuria 01/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 12/2016
1	Dengue (Dengue Fever) 01/2016
1	RNA Virus Infections 03/2015
1	Virus Diseases (Viral Diseases) 03/2015
1	Human Influenza (Influenza) 03/2015
1	Vesicular Stomatitis 03/2015
1	Retinoblastoma (Glioblastoma, Retinal) 01/2014
1	Anosmia 04/2013
1	Diabetes Mellitus 04/2011
1	Sinusitis 04/2011
1	Sensorineural Hearing Loss 02/2011
1	Ototoxicity 02/2011
1	Long Term Adverse Effects 02/2011
1	Otitis Externa 02/2011
1	Nasopharyngeal Carcinoma 02/2011
1	Otitis Media 02/2011
1	Zoster Sine Herpete 10/2008
1	Herpesviridae Infections (Herpesvirus Infection) 02/2003
1	Demyelinating Diseases (Demyelinating Disease) 11/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2013 - 01/2010
2	Phosphates (Orthophosphate)IBA 04/2013 - 02/2003
2	HydrogelsIBA 04/2013 - 01/2010
2	Prednisolone (Predate)FDA LinkGeneric 10/2008 - 11/2003
2	Acyclovir (Aciclovir)FDA LinkGeneric 11/2003 - 02/2003
1	CytokinesIBA 11/2019
1	UbiquitinIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	PolyubiquitinIBA 01/2019
1	Deubiquitinating Enzyme CYLDIBA 01/2019
1	Deubiquitinating EnzymesIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	N,N'- bis- (2,4- dimethyl- phenyl)- ethane- 1,2- diamineIBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Hexosaminidases (Hexosaminidase)IBA 01/2017
1	tax Gene Products (tax Gene Product)IBA 01/2017
1	CreatinineIBA 01/2017
1	ChlorophyllIBA 12/2016
1	Type A Botulinum Toxins (Botox)FDA Link 02/2016
1	OvalbuminIBA 02/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	InterferonsIBA 01/2016
1	VaccinesIBA 01/2016
1	Dual Specificity Phosphatase 1IBA 03/2015
1	Interferon Type IIBA 03/2015
1	Dual-Specificity PhosphatasesIBA 03/2015
1	NucleoproteinsIBA 09/2014
1	Viral DNAIBA 09/2014
1	PhosphoproteinsIBA 01/2014
1	EdaravoneIBA 12/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2013
1	Free Radical ScavengersIBA 12/2013
1	Skatole (3 Methylindole)IBA 04/2013
1	GelatinIBA 04/2013
1	Complementary DNA (cDNA)IBA 01/2013
1	Phosphatidate PhosphataseIBA 01/2013
1	MyogeninIBA 07/2012
1	Phospholipid Transfer ProteinsIBA 07/2012
1	Pathogen-Associated Molecular Pattern MoleculesIBA 07/2012
1	SteroidsIBA 04/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2011
1	Valacyclovir (Valtrex)FDA LinkGeneric 10/2008
1	Immunologic Factors (Immunomodulators)IBA 03/2005
1	Therapeutic UsesIBA 11/2003
1	BuffersIBA 02/2003
1	OsmiumIBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2018 - 11/2003
1	Tympanoplasty 04/2014
1	Intravenous Infusions 04/2013
1	Intraperitoneal Injections 04/2013
1	Denervation 07/2012
1	Radiotherapy 02/2011
1	Otoscopes 02/2011
1	Palliative Care (Palliative Therapy) 05/2009